金融业


资产 更改 日
Acadia Pharmaceuticals USD 1.79B 51.25M 2026-09
ALKERMES USD 4.44B 42.4M 2026-09
Alnylam Pharmaceuticals USD 7.99B 2.44B 2026-09
Biogen USD 32.05B 32.5M 2026-09
BioMarin Pharmaceutical USD 11.57B 154.21M 2026-09
Bristol-Myers Squibb USD 88.77B 1.14B 2026-09
Cara Therapeutics USD 23.53M 2.28M 2026-09
Corcept Therapeutics USD 1.03B 145.32M 2026-09
Cytokinetics USD 1.82B 99.77M 2026-09
Eisai JPY 1.52T 33.49B 2026-09
Eli Lilly USD 148.07B 5.79B 2026-09
Incyte USD 7.29B 585.39M 2026-09
J&J USD 197.42B 3.64B 2026-09
Moderna USD 13.47B 2.51B 2026-09
Neurocrine Biosciences USD 5.63B 268.3M 2026-09
Pfizer USD 204.54B 3.41B 2026-09
Prothena USD 283.52M 19.06M 2026-09
PTC Therapeutics USD 3.21B 42.76M 2026-09
Sarepta Therapeutics USD 3.17B 22.45M 2026-09
Ultragenyx Pharmaceutical USD 1.19B 77M 2026-09
Vanda Pharmaceuticals USD 488.95M 112.19M 2025-12
Vertex Pharmaceuticals USD 32.74B 5.31B 2026-09